SEC Form 4 · accession 0001140361-15-023162
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Mueller
Officer — VP, Corporate Controller
Period of report
May 31, 2015
Accepted (ET)
Jun 3, 2015 · 8:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 31, 2015 | F | 308 | $125.57 | D | 12,448 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction, which should have been reported on June 2, 2015, is being reported late due to an administrative oversight.